Eprinomectin + Praziquantel

Verify with FDA CVM →

620 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
620
Total Reports
29
Deaths Reported
470.0%
Death Rate

Active Ingredients

EprinomectinPraziquantel

Administration Routes

TopicalOtherUnknownOralTransdermalOphthalmicRespiratory (Inhalation)

Species Affected

Cat 578
Unknown 34
Human 8

Most Affected Breeds

Domestic Shorthair 356
Cat (unknown) 99
Unknown 42
Domestic Mediumhair 39
Domestic Longhair 38
Siamese 11
Maine Coon 7
Ragdoll 4
Persian 3
Russian 3

Most Reported Reactions

Hypersalivation 98
Vomiting 85
Lethargy (see also Central nervous system depression in 'Neurological') 83
Foaming at the mouth 60
Lack of efficacy (endoparasite) - tapeworm 57
Drooling 45
Incorrect route of drug administration 40
Dilated pupils 34
Lack of efficacy (endoparasite) - roundworm NOS 34
Application site hair loss 29
Ataxia 27
Not eating 24

Outcome Breakdown

Outcome Unknown
374 (63.6%)
Recovered/Normal
165 (28.1%)
Ongoing
20 (3.4%)
Died
16 (2.7%)
Euthanized
13 (2.2%)

Data Summary

Metric Value
Total adverse event reports 620
Reports involving death 29
Case-fatality rate (reported events) 470.0%
Distinct species in reports 3
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 2

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Eprinomectin + Praziquantel Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 620 adverse event reports referencing Eprinomectin + Praziquantel, including 29 reports in which the animal died — a 470.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredients on file: Eprinomectin, Praziquantel. Reported administration routes include Topical, Other, Unknown, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Eprinomectin + Praziquantel reports are Cat (578 reports), Unknown (34 reports), Human (8 reports), with Cat accounting for the largest share. Within those species, Domestic Shorthair (356), Cat (unknown) (99), Unknown (42) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Eprinomectin + Praziquantel are Hypersalivation (98), Vomiting (85), Lethargy (see also Central nervous system depression in 'Neurological') (83), Foaming at the mouth (60). Of the 588 reports with a coded outcome, Outcome Unknown is the leading category at 63.6%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Eprinomectin + Praziquantel.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial